About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 368178, 11 pages
http://dx.doi.org/10.1155/2013/368178
Research Article

Omega-3 Fatty Acids Inhibit Tumor Growth in a Rat Model of Bladder Cancer

1Laboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
2Department of Urology and Renal Transplantation, Coimbra University Hospital, 3000-075 Coimbra, Portugal
3Service of Anatomic Pathology, Coimbra University Hospital, 3000-075 Coimbra, Portugal

Received 24 April 2013; Accepted 4 June 2013

Academic Editor: Achille Cittadini

Copyright © 2013 Belmiro Parada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Grasso, “Bladder cancer: a major public health issue,” European Urology, vol. 7, no. 7, pp. 510–515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle, “Estimates of the cancer incidence and mortality in Europe in 2006,” Annals of Oncology, vol. 18, no. 3, pp. 581–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Kirkali, T. Chan, M. Manoharan et al., “Bladder cancer: epidemiology, staging and grading, and diagnosis,” Urology, vol. 66, no. 6, supplement, pp. 4–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Sylvester, A. P. M. Van Der Meijden, W. Oosterlinck et al., “Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials,” European Urology, vol. 49, no. 3, pp. 466–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. B. Malkowicz, H. van Poppel, G. Mickisch et al., “Muscle-invasive urothelial carcinoma of the bladder,” Urology, vol. 69, no. 1, supplement, pp. 3–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Zeegers, F. E. Tan, E. Dorant, and P. A. Van Den Brandt, “The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies,” Cancer, vol. 66, pp. 4–34, 2000.
  7. M. Kogevinas, A. 'T Mannetje, S. Cordier et al., “Occupation and bladder cancer among men in Western Europe,” Cancer Causes and Control, vol. 14, no. 10, pp. 907–914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Wolff, “The genetics of bladder cancer: a cytogeneticist's perspective,” Cytogenetic and Genome Research, vol. 118, no. 2–4, pp. 177–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Baffa, J. Letko, C. McClung, J. LeNoir, A. Vecchione, and L. G. Gomella, “Molecular genetics of bladder cancer: targets for diagnosis and therapy,” Journal of Experimental and Clinical Cancer Research, vol. 25, no. 2, pp. 145–160, 2006. View at Scopus
  10. E. Kunze, A. Schauer, and S. Schatt, “Stages of transformation in the development of N butyl N (4 hydroxybutyl) nitrosamine induced transitional cell carcinomas in the urinary bladder of rats,” Zeitschrift fur Krebsforschung und Klinische Onkologie, vol. 87, no. 2, pp. 139–160, 1976. View at Scopus
  11. S. Fukushima, M. Hirose, and H. Tsuda, “Histological classification of urinary bladder cancers in rats induced by N butyl N (4 hydroxybutyl)nitrosamine,” Gann, vol. 67, no. 1, pp. 81–90, 1976. View at Scopus
  12. P. A. Oliveira, A. Colaço, L. F. De La Cruz P, and C. Lopes, “Experimental bladder carcinogenesis-rodent models,” Experimental Oncology, vol. 28, no. 1, pp. 2–11, 2006. View at Scopus
  13. R. Montironi and R. Mazzucchelli, “Preneoplastic lesions and conditions of the urinary bladder,” EAU Update Series, vol. 1, no. 2, pp. 53–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sauter, F. Algaba, and M. Amin, “Tumors of the urinary system: non-invasive urothelial neoplasias,” in WHO Classification of Tumors of the Urinary System and Male Genital Organs, J. N. Eble, G. Sauter, J. L. Epstein, and I. Sesterhenn, Eds., pp. 29–34, IARCC Press, Lyon, France, 2004.
  15. J. T. Leppert, O. Shvarts, K. Kawaoka, R. Lieberman, A. S. Belldegrun, and A. J. Pantuck, “Prevention of bladder cancer: a review,” European Urology, vol. 49, no. 2, pp. 226–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Parada, J. Sereno, F. Reis et al., “Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis,” Cancer Biology and Therapy, vol. 8, no. 17, pp. 1615–1622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Parada, F. Reis, A. Figueiredo et al., “Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model,” British Journal of Urology International, vol. 107, no. 1, pp. 135–143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Parada, F. Reis, A. Pinto, et al., “Chemopreventive efficacy of atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties,” International Journal of Molecular Science, vol. 13, no. 7, pp. 8482–8499, 2012.
  19. J. C. Fernandes, J. Sereno, P. Garrido, et al., “Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model,” Marine Drugs, vol. 10, no. 12, pp. 2661–2675, 2012.
  20. M. La Guardia, S. Giammanco, D. Di Majo, G. Tabacchi, E. Tripoli, and M. Giammanco, “Omega 3 fatty acids: biological activity and effects on human health,” Panminerva Medica, vol. 47, no. 4, pp. 245–257, 2005. View at Scopus
  21. A. P. Simopoulos, “Omega-6/omega-3 essential fatty acids: biological effects,” World Review of Nutrition and Dietetics, vol. 99, pp. 1–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. De Lorgeril, “Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases,” Sub-Cellular Biochemistry, vol. 42, pp. 283–297, 2007. View at Scopus
  23. A. A. Farooqui, “N-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation,” Current Medicinal Chemistry, vol. 19, no. 4, pp. 532–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. C. Calder, “The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability,” Molecular Nutrients & Food Research, vol. 56, no. 7, pp. 1073–1080, 2012.
  25. L. Raffaelli, S. Serini, E. Piccioni et al., “N-3 polyunsaturated fatty acid effect in periodontal disease: state of art and possible mechanisms involved,” International Journal of Immunopathology and Pharmacology, vol. 21, no. 2, pp. 261–266, 2008. View at Scopus
  26. S. Serini, E. Piccioni, and G. Calviello, “Dietary n-3 PUFA vascular targeting and the prevention of tumor growth and age-related macular degeneration,” Current Medicinal Chemistry, vol. 16, no. 34, pp. 4511–4526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. MacLean, S. J. Newberry, W. A. Mojica et al., “Effects of omega-3 fatty acids on cancer risk: a systematic review,” Journal of the American Medical Association, vol. 295, no. 4, pp. 403–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. I. M. Berquin, I. J. Edwards, and Y. Q. Chen, “Multi-targeted therapy of cancer by omega-3 fatty acids,” Cancer Letters, vol. 269, no. 2, pp. 363–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, “Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies,” Nutrition and Cancer, vol. 61, no. 3, pp. 287–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Maclean, S. J. Newberry, W. A. Mojica et al., “Effects of omega-3 fatty acids on cancer,” Evidence Report-Technology Assessment, no. 113, pp. 1–4, 2005. View at Scopus
  31. M. Brausi, J. A. Witjes, D. Lamm et al., “A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group,” Journal of Urology, vol. 186, no. 6, pp. 2158–2167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-B. Lattouf, “Chemoprevention in bladder cancer: what's new?” Journal of the Canadian Urological Association, vol. 3, no. 6, supplement, pp. S184–S187, 2009. View at Scopus
  33. B. Stocco, K. Toledo, M. Salvador, M. Paulo, N. Koyama, and M. R. Torqueti Toloi, “Dose-dependent effect of resveratrol on bladder cancer cells: chemoprevention and oxidative stress,” Maturitas, vol. 72, no. 1, pp. 72–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. E. Goossens, F. Buntinx, S. Joniau et al., “Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium,” BMC Urology, vol. 12, article 8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Hori, E. Butler, and J. McLoughlin, “Prostate cancer and diet: food for thought?” British Journal of Urology International, vol. 107, no. 9, pp. 1348–1359, 2012.
  36. A. J. Cockbain, G. J. Toogood, and M. A. Hull, “Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer,” Gut, vol. 61, no. 1, pp. 135–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Signori, K. El-Bayoumy, J. Russo et al., “Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations,” Cancer Research, vol. 71, no. 19, pp. 6091–6096, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Norat, S. Bingham, P. Ferrari, et al., “Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition,” Journal of National Cancer Institute, vol. 97, no. 12, pp. 906–916, 2005.
  39. J. E. Manson, S. S. Bassuk, I.-M. Lee et al., “The Vitamin D and Omega-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease,” Contemporary Clinical Trials, vol. 33, no. 1, pp. 159–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Molinari, D. D'Eliseo, L. Manzi, L. Zolla, F. Velotti, and N. Merendino, “The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure,” Cancer Immunology, Immunotherapy, vol. 60, no. 10, pp. 1503–1507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Mackie, D. M. Sharma, A. J. Cooper, N. M. Harris, and B. A. Lwaleed, “Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 6, pp. 367–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Eynard, “Is the risk of the urinary tract tumorigenesis enhancced by a marginal chronic essential fatty acid deficiency (EFAD)?” Nutrition, vol. 14, no. 2, pp. 211–216, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. S. McClinton, L. E. F. Moffat, D. F. Horrobin, and M. S. Manku, “Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer,” British Journal of Cancer, vol. 63, no. 2, pp. 314–316, 1991. View at Scopus
  44. M. T. Brinkman, M. R. Karagas, M. S. Zens, A. R. Schned, R. C. Reulen, and M. P. Zeegers, “Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study,” British Journal of Nutrition, vol. 106, no. 7, pp. 1070–1077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Ohtani, T. Kakizoe, and Y. Nishio, “Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine,” Cancer Research, vol. 46, no. 4, pp. 2001–2004, 1986. View at Scopus
  46. K. Hattori, K. Iida, A. Joraku, S. Tsukamoto, H. Akaza, and R. Oyasu, “Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis,” British Journal of Urology International, vol. 97, no. 3, pp. 640–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Federico, F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio, “Chronic inflammation and oxidative stress in human carcinogenesis,” International Journal of Cancer, vol. 121, no. 11, pp. 2381–2386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Calviello, P. Palozza, E. Piccioni, et al., “Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis,” International Journal of Cancer, vol. 75, no. 5, pp. 699–705, 1998.
  49. A. Barascu, P. Besson, O. Le Floch, P. Bougnoux, and M.-L. Jourdan, “CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 2, pp. 196–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. D. Boudreau, K. H. Sohn, S. H. Rhee, S. W. Lee, J. D. Hunt, and D. H. Hwang, “Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways,” Cancer Research, vol. 61, no. 4, pp. 1386–1391, 2001. View at Scopus
  51. N. Kobayashi, R. J. Barnard, S. M. Henning et al., “Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2,” Clinical Cancer Research, vol. 12, no. 15, pp. 4662–4670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. W. E. Hardman, “(n-3) fatty acids and cancer therapy,” Journal of Nutrition, vol. 134, no. 12, supplement, pp. 3427S–3430S, 2004. View at Scopus
  53. C. W. Hendrickse, M. R. B. Keighley, and J. P. Neoptolemos, “Dietary ω-3 fats reduce proliferation and tumor yields at colorectal anastomosis in rats,” Gastroenterology, vol. 109, no. 2, pp. 431–439, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Fini, G. Piazzi, C. Ceccarelli et al., “Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in ApcMin/+ mice,” Clinical Cancer Research, vol. 16, no. 23, pp. 5703–5711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Calviello, S. Serini, and E. Piccioni, “n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved,” Current Medicinal Chemistry, vol. 14, no. 29, pp. 3059–3069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Boutros, P. Somasundar, A. Razzak, S. Helton, and N. J. Espat, “Omega-3 fatty acids: investigations from cytokine regulation to pancreatic cancer gene suppression,” Archives of Surgery, vol. 145, no. 6, pp. 515–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Spencer, C. Mann, M. Metcalfe et al., “The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential,” European Journal of Cancer, vol. 45, no. 12, pp. 2077–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Calviello, P. Palozza, F. Di Nicuolo, N. Maggiano, and G. M. Bartoli, “n-3 PUFA dietary supplementation inhibits proliferation and store- operated calcium influx in thymoma cells growing in Balb/c mice,” Journal of Lipid Research, vol. 41, no. 2, pp. 182–188, 2000. View at Scopus
  59. K. El Gehani, L. Al-Kikhia, N. Mansuri, K. Syrjänen, O. Al-Fituri, and A. Elzagheid, “Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31,” Libyan Journal of Medicine, vol. 6, article 6016, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. R. E. Harris, “Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer,” Sub-cellular biochemistry, vol. 42, pp. 93–126, 2007. View at Scopus
  61. A. Vecchini, V. Ceccarelli, F. Susta et al., “Dietary α-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells,” Journal of Lipid Research, vol. 45, no. 2, pp. 308–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. A. J. Vecchio, D. M. Simmons, and M. G. Malkowski, “Structural basis of fatty acid substrate binding to cyclooxygenase-2,” Journal of Biological Chemistry, vol. 285, no. 29, pp. 22152–22163, 2010. View at Publisher · View at Google Scholar · View at Scopus